GLP-1 receptor agonists semaglutide, tirzepatide, liraglutide are producing weight loss results that were virtually unheard of outside of bariatric surgery just five years ago. People are losing 10, 15, even 20 percent of their body weight. The headlines are extraordinary and, in many cases, the results genuinely are.
But there is a quiet problem sitting underneath those numbers that is not making the headlines and if you are currently taking a GLP-1 drug, or considering one, it is something you need to understand before you start.
The weight coming off is not all fat. A significant portion of it is muscle. And if you are not doing something specific to prevent that, the long-term consequences are considerably more serious than most weight loss clinics are telling their patients.
What GLP-1 Drugs Actually Do to Body Composition
GLP-1 drugs work by suppressing appetite, slowing gastric emptying, and reducing overall calorie intake often dramatically. The body, now running in a significant calorie deficit, begins breaking down stored tissue for energy.
In an ideal scenario, that tissue would be almost entirely fat. In reality, the body does not work that selectively. When calorie intake drops sharply and protein intake is inadequate which is almost universal among GLP-1 users because reduced appetite means reduced eating across the board the body breaks down muscle tissue alongside fat to meet its energy needs.
Clinical trial data on semaglutide shows that lean mass loss accounts for roughly 25 to 40 percent of total weight lost in people not following a structured resistance training programme. A person losing 20kg could be losing 5 to 8kg of muscle alongside the fat. That is not a minor side effect. That is a fundamental change to body composition that has real and lasting consequences.
Why Muscle Loss Matters More Than the Scale Suggests
Muscle is not just about aesthetics. It is the most metabolically active tissue in the body the primary driver of your resting metabolic rate. The more lean muscle you carry, the more calories your body burns at rest. Lose muscle, and your metabolism slows proportionally.
This creates a problem that extends well beyond the period of drug use. People who lose significant muscle mass during GLP-1 treatment arrive at their goal weight with a lower metabolic rate than before they started. When appetite eventually returns either because the drug is stopped or dosage is reduced the combination of a slower metabolism and returning hunger makes weight regain not just likely but almost physiologically inevitable.
This is a significant part of why the rebound data on GLP-1 drugs is so striking. Studies following people after stopping semaglutide show that the majority regain most of their lost weight within two years. Muscle loss during treatment is a major contributor to that outcome.
Beyond metabolism, muscle loss affects physical function, bone density, injury resilience, posture, and energy levels. For people over 40 for whom age-related muscle loss, or sarcopenia, is already a background concern losing additional lean mass during GLP-1 treatment can meaningfully accelerate physical decline.
The Protein Problem
The most direct driver of muscle loss on GLP-1 drugs is inadequate protein intake.
Muscle protein synthesis the process by which your body repairs and builds muscle tissue requires a consistent supply of dietary protein, particularly leucine-rich animal or soy-based sources. The minimum effective threshold for muscle preservation during a calorie deficit is generally cited at 1.6g of protein per kilogram of bodyweight per day. For active individuals and those over 40, that rises to 2.0g or above.
GLP-1 drugs make hitting those targets extremely difficult. When overall food intake drops to 1,000 to 1,400 calories per day not uncommon on higher doses of semaglutide or tirzepatide eating enough protein to protect muscle while leaving room for everything else becomes a genuine nutritional challenge.
The practical solution requires intentional prioritisation. Protein must come first at every meal not as an afterthought after bread, pasta, or whatever else is on the plate. High-density protein sources like Greek yoghurt, eggs, cottage cheese, chicken, fish, and quality protein supplements become more important than they would be under any other dietary circumstance. And total daily protein should be tracked, at least initially, to confirm that targets are being met rather than assumed.
Why Resistance Training Is the Other Half of the Solution
Protein intake alone is not sufficient to prevent muscle loss at the calorie levels GLP-1 users are typically eating. The other essential component is progressive resistance training and this is where the gap between what people are being told by prescribing clinics and what they actually need to do is most stark.
The physiological mechanism is straightforward. Resistance training sends a direct signal to the body that muscle tissue is needed and should be preserved. Without that signal, the body has no reason to prioritise muscle retention during a deficit. With it, muscle protein synthesis is upregulated and lean mass is protected even under significant calorie restriction.
The minimum effective dose for muscle preservation is two to three structured strength and conditioning sessions per week, built around compound movements squats, deadlifts, rows, pressing variations. These recruit the largest muscle groups, produce the strongest anabolic signalling response, and deliver the broadest stimulus for full-body muscle preservation.
This is not about building a competitive physique. It is about protecting the tissue you already have while the weight comes off so that what remains at the end of treatment is a leaner, stronger, more functional body rather than simply a lighter one.
Training on a Low Calorie Intake — What to Expect
One important caveat for anyone starting resistance training while on a GLP-1 drug: performance will be affected, particularly in the early weeks.
Significantly reduced calorie intake means reduced energy availability for training. Strength numbers may drop. Sessions may feel harder than expected. This is normal and does not mean training is not working it means the body is adapting to a new energy environment.
The appropriate response is to reduce training intensity and volume temporarily, build progressively as tolerance improves, and avoid the temptation to compensate with excessive cardio, which elevates cortisol, accelerates muscle breakdown, and compounds the problem you are trying to solve.
Three moderate strength sessions per week, with adequate rest between them, will consistently outperform five high-intensity sessions for muscle preservation in a calorie-restricted state. Less, done consistently, is considerably more effective than more, done sporadically.
The Long View: Building Results That Last
The people who get genuinely lasting results from GLP-1 drugs share a common characteristic. They do not treat the drug as a passive solution. They treat it as a window a period of reduced appetite and significant weight loss during which they build the fitness habits, muscle base, and nutritional knowledge that will sustain their results long after the prescription ends.
The drug creates the calorie deficit. Training determines what happens inside it. Protein intake determines what the body uses to fill that deficit. And the habits built during treatment determine whether the results last one year or a lifetime.
If you are currently taking a GLP-1 drug and you are not training, you are leaving the most important part of the equation undone.
Conclusion
GLP-1 drugs are genuinely powerful tools for weight loss. But weight loss and body transformation are not the same thing — and without structured resistance training and adequate protein intake, a significant proportion of what is lost will be muscle rather than fat.
The consequences of that are not cosmetic. They are metabolic, functional, and long-term. Protecting lean mass during GLP-1 treatment is not an optional extra. It is the difference between a result that lasts and one that reverses.
If you are taking semaglutide, tirzepatide, or any GLP-1 medication and want a training programme built specifically around your situation, book a free consultation with Julian Ernst at Tempo Performance. We work with clients across London and worldwide to ensure that whatever approach you are taking to weight loss, the outcome is built to last.